Trevi Therapeutics Inc

TRVINASDAQ · US

Holders

REDUCEDT+30
Heffernan Michael Thomas
Trevi Therapeutics Inc · NASDAQ
−20,952 sh · $316.2K
Filed 17 Sept 2026SEC Form 4view source
REDUCEDT+30
Heffernan Michael Thomas
Trevi Therapeutics Inc · NASDAQ
−100 sh · $1.6K
Filed 17 Sept 2026SEC Form 4view source
REDUCEDT+30
Heffernan Michael Thomas
Trevi Therapeutics Inc · NASDAQ
−100 sh · $1.6K
Filed 17 Sept 2026SEC Form 4view source
ACQUIREDT+30
Heffernan Michael Thomas
Trevi Therapeutics Inc · NASDAQ
+18,421 sh · $56.0K
Filed 17 Sept 2026SEC Form 4view source
ACQUIREDT+30
Heffernan Michael Thomas
Trevi Therapeutics Inc · NASDAQ
+21,052 sh · $70.1K
Filed 17 Sept 2026SEC Form 4view source
REDUCEDT+30
Heffernan Michael Thomas
Trevi Therapeutics Inc · NASDAQ
−18,321 sh · $276.5K
Filed 17 Sept 2026SEC Form 4view source
DISCLOSEDQuarterly
Viking Global Investors
Trevi Therapeutics Inc · NASDAQ
1,544,644 sh · $28.8M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Trevi Therapeutics Inc · NASDAQ
38,415 sh · $458.3K
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Viking Global Investors
Trevi Therapeutics Inc · NASDAQ
3,198,644 sh · $38.2M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Viking Global Investors
Trevi Therapeutics Inc · NASDAQ
3,198,644 sh · $40.0M
Filed 31 Dec 2025SEC 13Fview source